Comanche Biopharma’s $75 Million Series B Financing Round

Sonia Carcano North America Legal Chronicle
Tagged:

Foley & Lardner LLP recently represented New Enterprise Associates, Inc. as lead investor. Comanche Biopharma closed its $75 million Series B financing. New Enterprise Associates, Inc. acted…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Sonia Carcano

Author: Sonia Carcano

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here